Pahayahay, Novie .

HRN: 20-11-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
AMPICILLIN 1GM (VIAL)
03/31/2023
04/07/2023
IV
2G
Q6
Pregnancy Uterine 40 3/7 Weeks, In Labor
Waiting Final Action 
04/01/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/03/2023
IV
1.5gram
Q 8hrs
S/P Cesarean Section
Waiting Final Action 
04/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/01/2023
04/03/2023
IV
500mg
Q 8hrs X 6 Doses
S/P Cesarean Section
Waiting Final Action 
04/02/2023
CEFUROXIME 500MG (TAB)
04/02/2023
04/06/2023
PO
500mg
BID
S/P CS
Waiting Final Action 
04/02/2023
METRONIDAZOLE 500MG (TAB)
04/02/2023
04/06/2023
PO
500mg
TID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: